Therapeutics: hormone therapy for breast cancer
Wehrlin, N.
Revue de l'Infirmiere 33(11): 35-38
1983
ISSN/ISBN: 1293-8505 PMID: 6553966 Document Number: 206246
Document emailed within 1 workday
Related Documents
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17Joseph, K.S. 1995: Breast cancer and hormone-replacement therapy New England Journal of Medicine 333(20): 1356; Author Reply 1357-1358
Ersbøll, J. 2004: Breast cancer, mammography screening and hormone therapy Ugeskrift for Laeger 166(36): 3113-3114
Rageth, J.C.; Birkhäuser, M.; Castiglione, M. 1998: Hormone substitution therapy after breast cancer--a reevaluation Schweizerische Medizinische Wochenschrift 128(26): 1037-1042
Köhler, A.; Noss, W.; Dobberstein, N.; Stoltmann, R.; Pohl, J. 1986: Hormone therapy of metastasizing breast cancer with tamoxifen Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 41(1): 6-9
Levgur, M. 2004: Hormone therapy for women after breast cancer: a review Journal of Reproductive Medicine 49(7): 510-526
Chen, F.-P. 2009: Postmenopausal hormone therapy and risk of breast cancer Chang Gung Medical Journal 32(2): 140-147
Dryzhak, V.I. 1989: Estrogen antagonists and inhibitors in hormone therapy of breast cancer Voprosy Onkologii 35(7): 771-778
Snyder, G.M.; Sielsch, E.C.; Reville, B. 1998: The controversy of hormone-replacement therapy in breast cancer survivors Oncology Nursing Forum 25(4): 699-706; Quiz: 707-708
Cobleigh, M.A.; Norlock, F.E.; Oleske, D.M.; Starr, A. 1999: Hormone replacement therapy and high S phase in breast cancer JAMA 281(16): 1528-1530
Fentiman, I.S. 2002: 20. Oral contraceptives, hormone replacement therapy and breast cancer International Journal of Clinical Practice 56(10): 755-759
Predná, L.; Habánová, M.; Sláviková, E.; Wyka, J. 2015: Hormonal contraceptives and hormone replacement therapy as a possible factor of breast cancer Roczniki Panstwowego Zakladu Higieny 66(3): 269-274
Pinkerton, J.V.; Wilson, C.S.; Kaunitz, A.M. 2022: Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer Menopause 29(9): 1001-1004
Pannuti, F.; Martoni, A.; Piana, E.; Tomasi, L.; Grieco, A.; Farris, A.; Saccani, F.; Baroni, M. 1984: Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(4): 211-215
Inafuku, K.; Inari, H.; Goto, N.; Kawamoto, M.; Hatori, S.; Tanabe, H.; Masuda, M. 2014: A case of postmenopausal breast cancer becoming HER2 positive after neoadjuvant hormone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(4): 487-489
Vavilis, D.; Zafrakas, M.; Goulis, D.G.; Pantazis, K.; Agorastos, T.; Bontis, J.N. 2009: Hormone therapy for postmenopausal breast cancer survivors: a survey among obstetrician-gynaecologists European Journal of Gynaecological Oncology 30(1): 82-84
Ruan, X.; Seeger, H.; Mueck, A.O. 2012: Breast cancer risk during hormone therapy: experimental versus clinical data Minerva Endocrinologica 37(1): 59-74
Schouten, L.J.; de Rijke, J.M.; Schlangen, J.T.; Verbeek, A.L. 1997: Hormone replacement therapy and high incidence of breast cancer between mammographic screens Lancet 349(9058): 1104
Andrés, E.; Goichot, B.; Kurtz, J.E.; Dufour, P.; Imler, M.; Schlienger, J.L. 1999: Carcinomatous meningitis secondary to breast cancer. Spectacular response to hormone therapy Presse Medicale 28(2): 75
This, P. 1996: Hormone replacement therapy in menopausal women previously treated for breast cancer Presse Medicale 25(4): 141-144